国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Bacillus subtilis Probable multidrug resistance ABC transporter ATP-binding/permease protein YheI (yheI), partial CSB-YP519195BRJ1
CSB-EP519195BRJ1
CSB-BP519195BRJ1
CSB-MP519195BRJ1
CSB-EP519195BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized membrane protein yhjE (yhjE), partial CSB-YP519196BRJ1
CSB-EP519196BRJ1
CSB-BP519196BRJ1
CSB-MP519196BRJ1
CSB-EP519196BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis NTD biosynthesis operon protein NtdA (ntdA) CSB-YP519197BRJ
CSB-EP519197BRJ
CSB-BP519197BRJ
CSB-MP519197BRJ
CSB-EP519197BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yhjR (yhjR) CSB-YP519198BRJ
CSB-EP519198BRJ
CSB-BP519198BRJ
CSB-MP519198BRJ
CSB-EP519198BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized sodium-dependent transporter yhdH (yhdH), partial CSB-YP519199BRJ
CSB-EP519199BRJ
CSB-BP519199BRJ
CSB-MP519199BRJ
CSB-EP519199BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Probable anti-sigma-M factor yhdL (yhdL), partial CSB-YP519200BRJ1
CSB-EP519200BRJ1
CSB-BP519200BRJ1
CSB-MP519200BRJ1
CSB-EP519200BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein yhdX (yhdX) CSB-YP519201BRJ
CSB-EP519201BRJ
CSB-BP519201BRJ
CSB-MP519201BRJ
CSB-EP519201BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis NAD-dependent protein deacetylase (cobB) CSB-YP519202BRJ
CSB-EP519202BRJ
CSB-BP519202BRJ
CSB-MP519202BRJ
CSB-EP519202BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized membrane protein yhfC (yhfC), partial CSB-YP519203BRJ1
CSB-EP519203BRJ1
CSB-BP519203BRJ1
CSB-MP519203BRJ1
CSB-EP519203BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized N-acetyltransferase YhfO (yhfO) CSB-YP519204BRJ
CSB-EP519204BRJ
CSB-BP519204BRJ
CSB-MP519204BRJ
CSB-EP519204BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Probable biotin transporter BioY (bioY), partial CSB-YP519205BRJ1
CSB-EP519205BRJ1
CSB-BP519205BRJ1
CSB-MP519205BRJ1
CSB-EP519205BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein ylaB (ylaB), partial CSB-YP519206BRJ1
CSB-EP519206BRJ1
CSB-BP519206BRJ1
CSB-MP519206BRJ1
CSB-EP519206BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized membrane protein ylaH (ylaH), partial CSB-YP519207BRJ1
CSB-EP519207BRJ1
CSB-BP519207BRJ1
CSB-MP519207BRJ1
CSB-EP519207BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Lipid II flippase FtsW (ftsW), partial CSB-YP519208BRJ
CSB-EP519208BRJ
CSB-BP519208BRJ
CSB-MP519208BRJ
CSB-EP519208BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Protein tonB (tonB), partial CSB-YP519209CYY
CSB-EP519209CYY
CSB-BP519209CYY
CSB-MP519209CYY
CSB-EP519209CYY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cell division protein FtsA (ftsA) CSB-YP519210ELY
CSB-EP519210ELY
CSB-BP519210ELY
CSB-MP519210ELY
CSB-EP519210ELY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus acidophilus Beta-galactosidase small subunit (lacM) CSB-YP519211LME
CSB-EP519211LME
CSB-BP519211LME
CSB-MP519211LME
CSB-EP519211LME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable zinc-binding alcohol dehydrogenase Rv1895 (Rv1895) CSB-YP519212MVZ
CSB-EP519212MVZ
CSB-BP519212MVZ
CSB-MP519212MVZ
CSB-EP519212MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sensor histidine kinase component HK2 (Rv0601c), partial CSB-YP519213MVZ
CSB-EP519213MVZ
CSB-BP519213MVZ
CSB-MP519213MVZ
CSB-EP519213MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ribonuclease VapC4 (vapC4) CSB-YP519214MVZ
CSB-EP519214MVZ
CSB-BP519214MVZ
CSB-MP519214MVZ
CSB-EP519214MVZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>